지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.8
- 수록면
- 179 - 184 (6page)
이용수
초록· 키워드
오류제보하기
Backgrounds/Aims: Hepatocellular carcinoma (HCC) recurrence remains a great concern following hepatic resection and liver transplantation. We investigated the metformin-induced cytotoxic effects on sorafenib in an in vitro study using HCC cell lines. Methods: This research was conducted through an in vitro study using one HepG2.2.15 liver tumor and two patient-derived graft HCC cell lines. Results: An in vitro study revealed noticeable cytotoxic effects of metformin as well as noticeable synergistic cytotoxic effects of metformin and sorafenib on cell viability. Assays for the mechanisms of action of antitumor effects revealed that alpha-fetoprotein expression was suppressed by both metformin and sorafenib, but no synergistic effect was observed. LC3-I and LC3-II assays revealed the synergistic upregulation of autophagy and assays for IL-1, IL-6, p53, and TNF- revealed the synergistic upregulation of cell damage and apoptosis. In contrast, metformin did not affect HBx expression, thus no noticeable synergistic effect was considered to be present. Conclusions: Our in vitro study demonstrated cytotoxic effects of metformin and synergistic antitumor effects of sorafenib. These results should be verified in further clinical studies with patients of advanced HCC.
목차
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Absence of antitumor effects of metformin in sorafenib-treated patients with hepatocellular carcinoma recurrence after hepatic resection and liver transplantation
Annals of Hepato-Biliary-Pancreatic Surgery
2018 .11
-
Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib
Yonsei Medical Journal
2017 .01
-
The strategy for the treatment of hepatocellular carcinoma
대한동의병리학회 학술대회논문집
2015 .10
-
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
Clinical and Molecular Hepatology
2015 .01
-
Sorafenib potentiates ABT-737-induced apoptosis in human oral cancer cells
한국실험동물학회 학술발표대회 논문집
2015 .08
-
Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
Cancer Research and Treatment
2016 .01
-
An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenib
Annals of Hepato-Biliary-Pancreatic Surgery
2015 .02
-
Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review
Clinical and Molecular Hepatology
2017 .01
-
Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line
Clinical and Molecular Hepatology
2020 .01
-
Tumor lysis syndrome following sorafenib treatment in hepatocellular carcinoma
영남의대학술지
2015 .01
-
HCC 재발환자에서 sorafenib 적용 증례
WITH CAP(COMPANION ANIMAL PRACTICE)
2021 .04
-
Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
Journal of Liver Cancer
2021 .09
-
Sensitization of hepatocellular carcinoma cells against sorafenib treatment with autophagy regulation
한국실험동물학회 학술발표대회 논문집
2019 .07
-
Effects of the mixed formulation of sorafenib and blue honeysuckle on the pharmacokinetics profiles of sorafenib
대한예방한의학회지
2019 .01
-
Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
Journal of Korean Medical Science
2018 .01
-
A case report of advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy and sorafenib combination therapy followed by metastasectomy of lung and muscle metastases
Journal of Liver Cancer
2022 .03
-
Usefulness of sarcopenia in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment
대한외과학회 학술대회 초록집
2019 .10
-
Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
Clinical and Molecular Hepatology
2020 .01
-
Synergistic effect prediction and assessment of anti-cancer combination
환경독성보건학회 심포지엄 및 학술대회
2022 .05
-
Effect of autophagy modulation on sorafenib-induced cytotoxicity in hepatocellular carcinoma cells
한국실험동물학회 학술발표대회 논문집
2019 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2018-514-003397382